| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net (loss) income | -1,346,100 | 20,900 |
| Profits interest distribution expenses | 1,379,700 | - |
| Net realized gains on investments | 6,200 | 2,700 |
| Net unrealized gains on investments | 37,200 | 1,200 |
| Earnings from equity method investments | 1,500 | 1,200 |
| Share-based compensation expenses | 22,600 | 5,400 |
| Depreciation and amortization | 25,700 | 15,700 |
| Deferred income tax benefit | -11,800 | -10,700 |
| Net foreign exchange losses | -14,900 | -17,300 |
| Net accretion of discount on fixed maturity securities and short-term investments | 5,900 | 3,900 |
| Other, net | -2,800 | -400 |
| Premiums receivable | 102,700 | 112,700 |
| Ceded unearned premiums | 280,600 | 325,100 |
| Reinsurance recoverables on unpaid losses and lae | 460,500 | 327,100 |
| Other reinsurance recoverables | 152,800 | 112,700 |
| Deferred acquisition costs | -1,900 | -9,800 |
| Unpaid losses and loss adjustment expenses | 483,600 | 321,200 |
| Unearned premiums | 292,100 | 282,900 |
| Payables to reinsurers | 86,300 | 253,100 |
| Deferred ceding commissions | 48,700 | 59,500 |
| Funds held under reinsurance | -383,100 | -230,900 |
| Insurance balances payable | 23,400 | -19,200 |
| Other assets, accounts payable and other liabilities | -23,700 | -8,700 |
| Net cash provided by operating activities | 383,200 | 309,300 |
| Equity securities | 0 | 0 |
| Fixed maturity securities | 150,800 | 80,800 |
| Equity method investments | 1,100 | - |
| Other investments | 3,600 | - |
| Maturities of fixed maturity securities | 40,000 | 28,900 |
| Fixed maturity securities | 397,900 | 262,900 |
| Equity method investments | 800 | 400 |
| Net change in short-term investments | -4,900 | 10,200 |
| Purchases of subsidiaries, net of cash acquired | 9,900 | 1,400 |
| Capitalized technology development expenditures | 29,800 | 17,300 |
| Other, net | 300 | 300 |
| Net cash used in investing activities | -238,300 | -182,800 |
| Redemption of class c convertible preference shares | 175,300 | - |
| Issuance of common shares, net of issuance costs | 392,000 | - |
| Credit facility borrowings | 5,000 | 5,000 |
| Credit facility repayment | 5,000 | 0 |
| Issuance of debt, net of issuance costs | 0 | - |
| Payment of debt | 0 | - |
| Dividends paid to non-controlling interests | 7,200 | 4,100 |
| Net cash provided by (used in) financing activities | 209,500 | 900 |
| Net increase in cash, cash equivalents and restricted cash | 354,400 | 127,400 |
| Effect of exchange rate changes on cash | 48,500 | - |
| Cash and cash equivalents at beginning of period | 1,273,000 | - |
| Cash and cash equivalents at end of period | 1,675,900 | - |
Accelerant Holdings (ARX)
Accelerant Holdings (ARX)